Furthermore, a larger fraction of CD4+ resting T cells and Tregs were found in high-risk cases (Figure 3G), whereas the fractions of CD4+ naïve T cell, CD4+ activated T cell, and gamma delta T cells were extremely low in the tested glioma cases. The gene discussed is CD4; the disease is central nervous system cancer.